Overview
- 174 inspections across 136 sites are on record.
- 290 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-07-08.
At a glance
Inspections
174
Sites
136
Observations
290
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Blair M. Brengle, M.D. | 8 Jul 2021 | Human Drugs | View 483 → |
| Scott T. Guenthner M.D. | 3 Jun 2020 | Human Drugs | |
| Eli Lilly & Company | 20 Mar 2020 | Human Drugs | |
| Indiana University IRB | 14 Feb 2020 | Medical Devices & Rad Health | View 483 → |
| Eli Lilly & Company | 17 Jan 2020 | Human Drugs |
Sites inspected
Blair M. Brengle, M.D.Indianapolis, United States1 insp.
Scott T. Guenthner M.D.Plainfield, United States1 insp.
Eli Lilly & CompanyIndianapolis, United States2 insp.
Indiana University IRBIndianapolis, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Corrine M Carter15 shared
Andrea D Swingle4 shared
Neali H Lucas3 shared
Dawn C Olenjack3 shared
Brian M Campbell3 shared
Melanie N Daniels2 shared
Ifueko Osemwota2 shared
Kimberly Y Martin2 shared
Bleta Vuniqi2 shared
Dina A Tallman1 shared
Full investigator report
Get the verbatim findings behind Myra K Casey's 290 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site